Severe Central Nervous System Demyelination in Sanfilippo Disease
Mahsa TaherzadehiD, Erjun ZhangiD, Irene LondoñoiD, Sheng‐Kwei SongiD, Sophie WangiD, Jonathan D. CooperiD, Timothy E. KennedyiD, Carlos Ramón MoralesiD, Zesheng CheniD, Gregory Anton LodygenskyiD, Alexey V. PshezhetskyiD
Abstract
Neurodegeneration and chronic progressive neuroinflammation are well-documented in neurological lysosomal storage diseases, including Sanfilippo disease or mucopolysaccharidosis III (MPS III). Since chronic neuroinflammation has been linked to white matter tract pathology and defects in axonal transmission, we analysed axonal myelination and white matter density in the mouse model of MPS IIIC and human post-mortem brain samples from MPS IIIA, C, and D patients. Analyses of corpus callosum (CC) and spinal cord tissues by immunohistochemistry revealed substantially reduced levels of myelin-associated proteins including Myelin Basic Protein, Myelin Associated Glycoprotein, and Myelin Oligodendrocyte Glycoprotein. Furthermore, ultrastructural analyses revealed disruption of myelin sheath organization and reduced myelin thickness in the brains of MPS IIIC mice and human MPS IIIC patients compared to healthy controls. Oligodendrocytes (OLs) in the CC of MPS IIIC mice were scarce, while examination of the remaining cells revealed numerous enlarged lysosomes containing heparan sulfate, GM3 ganglioside or "zebra bodies" consistent with accumulation of lipids and myelin fragments. In addition, OLs contained swollen mitochondria with largely dissolved cristae, resembling those previously identified in the dysfunctional neurons of MPS IIIC mice. When brains of 7-month-old MPS IIIC mice were analysed by ex-vivo Diffusion Basis Spectrum Imaging to assess microarchitectural changes in the corpus callosum, we found compelling signs of demyelination (26% increase in radial diffusivity) and tissue loss (76% increase in hindered diffusivity). Our findings demonstrate an import role for white matter injury in the pathophysiology of MPS III. Moreover, this study reveals specific parameters and brain regions for MRI analysis, a crucial non-invasive method to evaluate disease progression and therapeutic response in neurological lysosomal storage diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 1.77
- Field percentile
- top 15%
- Organism
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systems-level investigation of mucopolysaccharidosis IIIA identifies deficient synaptic activity as a key driver of disease progression
Alon M. Douek, Adrian Salavaty, … Jan Kaslin·bioRxiv·Oct 3, 2022
- Early defects in lysosomal storage diseases disrupt excitatory synaptic transmission
Camila De Britto Pará De Aragão, Luigi Bruno, … Alexey V. Pshezhetsky·bioRxiv·Jul 6, 2020
- Zebrafish models of Mucopolysaccharidosis IIIA, IIIB, and IIIC show hyperactivity, neuroinflammation and changes in oligodendrocyte cell state
Ewan Gerken, Syahida Ahmad, … Michael T. Lardelli·bioRxiv·Aug 2, 2023
- Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteins
TianMeng Xu, Rachel Heon‐Roberts, … Alexey V. Pshezhetsky·Journal of Clinical InvestigationPeer-reviewed·Jun 17, 2025
- Cognitive impairment and progressive neuroinflammation in mucopolysaccharidosis IIIA mice expressing the R245H Sgsh variant
Adeline A. Lau, Paul J. Trim, … Kim M. Hemsley·bioRxiv·Jul 15, 2026
- Loss of SPNS1, a lysosomal transporter, in the nervous system causes dysmyelination and white matter dysplasia
Yoshinobu Ichimura, Yuki Sugiura, … Masaaki Komatsu·bioRxiv·May 29, 2024